期刊文献+

mIL-18腺病毒载体构建及在大鼠骨髓间充质干细胞中的表达

Construction of adenovirus vectors contained mIL-18and expression in rat mesenchymal stem cells
下载PDF
导出
摘要 目的构建表达mIL-18基因的腺病毒载体,并转染大鼠骨髓间充质干细胞(rBMSCs),观察其在rBMSCs中的表达,为脑胶质瘤的基因治疗实验研究奠定基础。方法 mIL-18基因亚克隆于穿梭质粒pAdtrackCMV上,构建的pAdtrackCMV-mIL-18线性化后转化已含有腺病毒骨架质粒pAdEasy-1的大肠杆菌BJ5183感受态细胞,挑选同源重组质粒,线性化后HEK293细胞包装,CsCI纯化。体外分离培养大鼠骨髓间充质干细胞,流式细胞仪检测细胞免疫表型;然后转染rBMSCs,通过荧光显微镜、RT-PCR、ELISA等方法检测mIL-18表达。结果成功构建了绿色荧光蛋白标记的腺病毒Ad-mIL-18,并在rBMSCs中高效表达。结论 pAdEasy-1是基因转染的高效系统,腺病毒Ad-mIL-18转染的rBMSCs可以作为脑肿瘤基因治疗研究的种子细胞。 Objective To construct adenovirus vectors contained milL-18 and observation the expression in rBMSCs and explore experiment study for gene therapy of glioma. Methods mIL-18 gene was subcloned into the shuttle plasmid pAdtrackCMV, then linearized the vector and convert competent cell BJ5183 which contain the adenovirus frame plasmid pAdEasy-1. The homologous recombination plasmid was packaged by HEK293 cells and purified by CsCI. The cell im- munophenotype was detected by flow cytometry. The expression of mIL-18 was measured by fluorescence microscope, RT-PCR and ELISA. Results The adenovirus vector Ad- mIL-18 was successfully constructed, which was labeled by green fluorescent protein (GFP) and effectively expressed in rBMSCs. Conclusion pAdEasy-1 is an effective gene trans- fection system, rBMSCs transfected with Ad- mIL-18 can serve as the seeds cells for the gene therapy of glioma.
出处 《西部医学》 2012年第6期1067-1070,共4页 Medical Journal of West China
关键词 白介素-18 腺病毒载体 骨髓间充质干细胞 Interleukin-18 Adenovirus vector Bone marrow mesenchymal stem cell
  • 相关文献

参考文献17

  • 1Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 regulates both Thl and Th2 responses [J]. Annual Review of Immunology, 2001, 19(1):423-474.
  • 2Gracie JA, Robertson SE, Mclnnes IB. Interleukin-18 [J]. Journal of Leukocyte Biology, 2003, 73(2)1213-224.
  • 3Micallef MJ, Yoshida K, Kawai S, et al. In vlvo antitumor effects of murine interferon-inducing factor/interleukin-18 in mice syngeneic Meth A sarcoma malignant ascites[J]. Cancer.Immunother, 1997, 43(6) :361-367.
  • 4Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, et al. Antitumor effect of genetically engineered mes- enehymal stem cells in a rat glioma model [J].Gene Therapy, 2004, 11 :1155-1164.
  • 5Hamada H, Kobune M, Nakamura K, etal. Mesenchymal stem cells (MSC) as therapeutic eytoreagents for gene therapy [J]. Cancer Sci 2005, 96(3):149-156.
  • 6He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses [J]. Proe Natl Aead Sci USA,1998,95(5) :2509-2514.
  • 7Matsui K, Yoshimoto T, TsutsuiH, et al. Propioniba-cteriam- acne treatment diminishes CD4 q- NK1. 1 + T cell sbutinduees type 1 T cells in the liver by induction of IL-12 and IL- 18production from kupffer ceils [J]. J Immunol, 1997,159 (1) : 97.
  • 8Dao T, Ohashi K, Kayano T, et al. Interferon-g-inducing fac- tor, a novel cytokine, enhances FasLigand-mediated cytotxiclty of routine the lperl cells [J]. Cell Immunol, 1996,173 (2) : 230.
  • 9Lauwerys BR, renauld Jc, Houssiau FA. Synergistic prolifera- tion and activation of nature killer cells by interleukin- 18andinterleukln-12[J]. Cytokine. 1999,11 (11) ~ 822-830.
  • 10Micallef MJ, Yoshida K, Kawai S, et al. In vivo antitumor effects of murine interferon-inducing factor/interleukin-18 in mice syngeneie Meth A sarcoma malignant ascites[J]. Cancer Immunother. 1997, 43(6) : 361-367.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部